Is Starteck Fin. overvalued or undervalued?
As of November 4, 2025, Starteck Fin. is considered overvalued with a PE ratio of 22.51, compared to peers like Bajaj Finance at 37.67 and Life Insurance at 11.76, despite a strong five-year return of 525.32%, which has recently underperformed against the Sensex.
As of 4 November 2025, the valuation grade for Starteck Fin. has moved from fair to expensive, indicating a shift in the perceived value of the company. The verdict is that Starteck Fin. is currently overvalued. Key ratios include a PE ratio of 22.51, an EV to EBIT of 17.75, and a Price to Book Value of 1.26, which suggest that the company's valuation is high relative to its earnings and book value.In comparison to its peers, Bajaj Finance is categorized as very expensive with a PE ratio of 37.67, while Life Insurance is considered very attractive with a PE of 11.76. This highlights that Starteck Fin.'s valuation is not only high but also less favorable compared to some of its peers. Additionally, while Starteck Fin. has shown a strong return over the past five years at 525.32%, its recent performance has lagged behind the Sensex, particularly in the year-to-date comparison.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
